https://www.zacks.com/stock/news/2234147/morgan-stanley-ms-mulling-to-offer-spot-bitcoin-etfs?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2234147
Feb 29, 2024 - Morgan Stanley (MS) is exploring the addition of spot bitcoin ETF offerings to its customers on its large brokerage platform.
zc:5780365912020068187
0
https://www.zacks.com/stock/news/2234547/morgan-stanley-ms-expands-in-uae-with-office-in-abu-dhabi?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2234547
Mar 01, 2024 - Morgan Stanley (MS) establishes an office in Abu Dhabi to expand its footprint in the Middle East. The move is in line with its efforts to gain business opportunities from the capital markets in the region.
zc:-2816418132612301129
0
https://seekingalpha.com/article/4679126-contineum-therapeutics-seeks-150-million-ipo-for-ms-treatments?source=feed_tag_ipo_analysis
Mar 19, 2024 - Contineum Therapeutics plans to raise $150 million through an IPO for developing advanced medical treatments, with strong institutional support and a key...
0
sa:6929378979809264799
0
https://www.zacks.com/commentary/2244021/top-stock-reports-for-disney-morgan-stanley-stryker?cid=CS-ZC-FT-research_daily-2244021
Mar 21, 2024 - Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Company (DIS), Morgan Stanley (MS) and Stryker Corporation (SYK).
zc:8043707435157316040
0
https://www.zacks.com/stock/news/2245173/morgan-stanley-ms-declines-more-than-market-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2245173
Mar 22, 2024 - In the most recent trading session, Morgan Stanley (MS) closed at $91.95, indicating a -1.55% shift from the previous trading day.
zc:466172564399148638
0
https://www.zacks.com/stock/news/2245569/markets-await-pce-core-pce-inflation-data?cid=CS-ZC-FT-economic_highlights-2245569
Mar 25, 2024 - Markets Await PCE/Core-PCE Inflation Data
zc:-8639727766891542919
0
https://www.zacks.com/stock/news/2252141/will-morgan-stanley-ms-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2252141
Apr 08, 2024 - Morgan Stanley (MS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zc:1519048354439221186
0
https://www.zacks.com/stock/news/2253844/ahead-of-morgan-stanley-ms-q1-earnings-get-ready-with-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2253844
Apr 11, 2024 - Beyond analysts' top -and-bottom-line estimates for Morgan Stanley (MS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
zc:8571913413417078274
0
https://seekingalpha.com/news/4090283-clene-stock-rallies-post-market-on-ms-drug-data?source=feed_sector_healthcare
Apr 16, 2024 - Clene (CLNN) stock rallied 52% post-market Tuesday after the company presented positive Phase 2 data for its drug CNM-Au8 in the treatment of multiple sclerosis. Read more here.
0
sa:14836347518107393
0
https://www.zacks.com/stock/news/2259447/are-you-looking-for-a-high-growth-dividend-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-2259447
Apr 22, 2024 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Morgan Stanley (MS) have what it takes? Let's find out.
zc:1629615218597221850
0